About Rebound Therapeutics
Rebound Therapeutics is a company based in Irvine (United States) founded in 2015 was acquired by Integra LifeSciences in September 2019.. Rebound Therapeutics has raised $20.26 million across 2 funding rounds from investors including Integra LifeSciences.
- Headquarter Irvine, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$20.26 M (USD)
in 2 rounds
-
Latest Funding Round
$16.5 M (USD), Series A
Jul 26, 2017
- Investors
-
Employee Count
Employee Count
-
Acquired by
Integra LifeSciences
(Sep 09, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Rebound Therapeutics
Rebound Therapeutics has successfully raised a total of $20.26M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $16.5 million completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $16.5M
-
First Round
First Round
(29 Dec 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2017 | Amount | Series A - Rebound Therapeutics | Valuation |
investors |
|
| Dec, 2015 | Amount | Series A - Rebound Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Rebound Therapeutics
Rebound Therapeutics has secured backing from 1 investor. Prominent investors backing the company include Integra LifeSciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified medical devices are developed for healthcare applications.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rebound Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rebound Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rebound Therapeutics Comparisons
Competitors of Rebound Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Rebound Therapeutics
When was Rebound Therapeutics founded?
Rebound Therapeutics was founded in 2015.
Where is Rebound Therapeutics located?
Rebound Therapeutics is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Is Rebound Therapeutics a funded company?
Rebound Therapeutics is a funded company, having raised a total of $20.26M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.76M, raised on Dec 29, 2015.
What does Rebound Therapeutics do?
Rebound Therapeutics was founded in 2015 and is headquartered in Irvine, United States. Single-use, disposable devices for access, imaging, and illumination are developed by the company for minimally invasive procedures. These include spine and orthopedic surgery, thoracic and general abdominal surgery, and neurosurgery. Operations focus on the medical device sector, with products designed to support surgical precision in these areas.
Who are Rebound Therapeutics's investors?
Rebound Therapeutics has 1 investor. Key investors include Integra LifeSciences.